Zurich Insurance Group’s Dr. Reddy's Laboratories RDY Stock Holding History

Zurich Insurance Group’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-191,397	Closed	-$2.65M	–	380
2026 Q1	$2.65M	Hold	191,397	–	–	0.02%	254
2025 Q4	$2.69M	Hold	191,397	–	–	0.02%	213
2025 Q3	$2.68M	Buy	191,397 +30,527	+19%	+$439K	0.02%	173
2025 Q2	$2.42M	Buy	+160,870	New	+$2.3M	0.02%	171

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Zurich Insurance Group's RDY Position: Q2 2026 in Review

Zurich Insurance Group sold out of Dr. Reddy's Laboratories (RDY) in Q2 2026, closing a stake of 191,397 shares — an estimated $2.65M sold.

Zurich Insurance Group first reported a position in RDY in Q2 2025 and held it in 4 quarters. The position peaked at $2.69M in Q4 2025. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

Zurich Insurance Group reported no remaining Dr. Reddy's Laboratories position as of Q2 2026 after selling out during the quarter.
Zurich Insurance Group sold 191,397 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $2.65M.
Zurich Insurance Group first reported a position in Dr. Reddy's Laboratories in Q2 2025 and held it in 4 quarters.
Zurich Insurance Group's Dr. Reddy's Laboratories position peaked at $2.69M in Q4 2025.
238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Zurich Insurance Group's 13F filing for Q2 2026, filed 14 Aug 2026.